A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms
Public ClinicalTrials.gov record NCT04435600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Active-Controlled, Efficacy Assessor-Blinded Study to Evaluate Pharmacokinetics, Safety and Efficacy of Risankizumab in Patients From 6 to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis
Study identification
- NCT ID
- NCT04435600
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 139 participants
Conditions and interventions
Conditions
Interventions
- Risankizumab Drug
- Ustekinumab Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 13, 2020
- Primary completion
- Feb 11, 2024
- Completion
- Oct 14, 2024
- Last update posted
- May 19, 2025
2020 – 2024
United States locations
- U.S. sites
- 21
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Department of Dermatology /ID# 218834 | Birmingham | Alabama | 35233 | — |
| First OC Dermatology /ID# 217733 | Fountain Valley | California | 92708 | — |
| Integrative Skin Science and Research /ID# 221741 | Sacramento | California | 95815 | — |
| University of California San Diego - Rady Children's Hospital San Diego /ID# 217906 | San Diego | California | 92123 | — |
| Rybear, Inc /ID# 223164 | Fort Lauderdale | Florida | 33316-1952 | — |
| Solutions Through Adv Rch /ID# 217936 | Jacksonville | Florida | 32256 | — |
| Olympian Clinical Research- St. Petersburg /ID# 217941 | St. Petersburg | Florida | 33709-1405 | — |
| Advanced Clinical Research Institute /ID# 222706 | Tampa | Florida | 33607 | — |
| University Dermatology and Vein Clinic, LLC /ID# 222778 | Darien | Illinois | 60561 | — |
| Duplicate_Arlington Dermatology /ID# 217472 | Rolling Meadows | Illinois | 60008 | — |
| Duplicate_Skin Cancer and Dermatology Institute (SCDI) /ID# 221738 | Reno | Nevada | 89052 | — |
| Duplicate_Forest Hills Dermatology Group /ID# 227941 | Kew Gardens | New York | 11415 | — |
| Univ Hosp Cleveland /ID# 228483 | Cleveland | Ohio | 44106 | — |
| The Ohio State University /ID# 217808 | Columbus | Ohio | 43210 | — |
| Apex Clinical Research Center /ID# 228537 | Mayfield Heights | Ohio | 44124 | — |
| Vital Prospects Clinical Research Institute, PC /ID# 217960 | Tulsa | Oklahoma | 74136-7049 | — |
| Medical University of South Carolina /ID# 217735 | Charleston | South Carolina | 29425 | — |
| Arlington Research Center, Inc /ID# 217471 | Arlington | Texas | 76011 | — |
| West Virginia University Hospitals /ID# 228352 | Morgantown | West Virginia | 26506 | — |
| Clinical Investigation Specialist, Inc - Kenosha /ID# 223161 | Kenosha | Wisconsin | 53144-1782 | — |
| Wisconsin Medical Center /ID# 240005 | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04435600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2025 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04435600 live on ClinicalTrials.gov.